Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SORRENTO THERAPEUTICS, INC.

(SRNE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about SORRENTO THERAPEUTICS, INC.
12/07Sorrento Therapeutics Starts Enrollment in Mid-Stage Trial of Resiniferatoxin to Treat ..
MT
12/07Sorrento Begins Enrollment in Phase 2 Trial of Resiniferatoxin (RTX) for the Treatment ..
GL
12/07Sorrento Begins Enrollment in Phase 2 Trial of Resiniferatoxin (RTX) for the Treatment ..
GL
12/07Sorrento Therapeutics, Inc. Begins Enrollment in Phase 2 Trial of Resiniferatoxin for t..
CI
12/07Sorrento Therapeutics Secures Accreditation for San Diego Clinical Laboratory
MT
12/07Sorrento Therapeutics' Clinical Laboratory Receives Accreditation From the College of A..
AQ
12/07Scilex Holding Company, a Sorrento Therapeutics Inc. Subsidiary, and Vickers Vantage Co..
AQ
12/06Sorrento Receives Orders of COVISTIX for Commercial Launch in Brazil
GL
12/06Sorrento Receives Orders of COVISTIX for Commercial Launch in Brazil
GL
12/06Sorrento Unit Scilex Plans Business Combination With Blank-Check Firm Vickers Vantage C..
MT
12/06SCILEX HOLDING COMPANY, A SORRENTO T : VCKA) (“SPAC”) Enter into Letter of Int..
PU
12/06SCILEX HOLDING COMPANY, A SORRENTO T : VCKA) (“SPAC”) Enter into Letter of Int..
AQ
12/06Sorrento Announces Publication of a Series of Novel SARS-CoV-2 Main Protease Inhibitors..
AQ
12/05Sorrento Announces Publication of a Series of Novel SARS-CoV-2 Main Protease (MPRO) Inh..
GL
12/05Sorrento Announces Publication of Series of Novel Sars-Cov-2 Main Protease Inhibitors f..
CI
More most relevant news
All news about SORRENTO THERAPEUTICS, INC.
12/07Sorrento Therapeutics Starts Enrollment in Mid-Stage Trial of Resiniferatoxin to Treat ..
MT
12/07Sorrento Begins Enrollment in Phase 2 Trial of Resiniferatoxin (RTX) for the Treatment ..
GL
12/07Sorrento Begins Enrollment in Phase 2 Trial of Resiniferatoxin (RTX) for the Treatment ..
GL
12/07Sorrento Therapeutics, Inc. Begins Enrollment in Phase 2 Trial of Resiniferatoxin for t..
CI
12/07Sorrento Therapeutics Secures Accreditation for San Diego Clinical Laboratory
MT
12/07Sorrento Therapeutics' Clinical Laboratory Receives Accreditation From the College of A..
AQ
12/07Scilex Holding Company, a Sorrento Therapeutics Inc. Subsidiary, and Vickers Vantage Co..
AQ
12/06Sorrento Receives Orders of COVISTIX for Commercial Launch in Brazil
GL
12/06Sorrento Receives Orders of COVISTIX for Commercial Launch in Brazil
GL
12/06Sorrento Unit Scilex Plans Business Combination With Blank-Check Firm Vickers Vantage C..
MT
More news
News in other languages on SORRENTO THERAPEUTICS, INC.
12/07Sorrento Therapeutics commence le recrutement dans un essai de mi-parcours de la résini..
12/07Sorrento Therapeutics obtient l'accréditation du laboratoire clinique de San Diego
12/06Scilex, unité de Sorrento, prévoit un regroupement d'entreprises avec l'entreprise à ch..
11/16La branche pharmaceutique de Lee recrute son premier patient dans le cadre d'un essai c..
11/03Sorrento Therapeutics obtient l'approbation du Brésil pour le test Covistix COVID-19 ; ..
11/01Le partenaire de licence de Sorrento dépose une demande de nouveau médicament en Chine ..
10/27Les autorités réglementaires chinoises vont examiner la demande de nouveau médicament d..
10/20Sorrento Therapeutics obtient le marquage CE et l'enregistrement du dispositif pour le ..
10/13Sorrento obtient l'autorisation de la FDA américaine pour les essais cliniques du conju..
09/28L'unité pharmaceutique de Lee obtient le feu vert pour soumettre une demande de nouveau..
More news
Analyst Recommendations on SORRENTO THERAPEUTICS, INC.
08/09SORRENTO THERAPEUTICS : HC Wainwright Adjusts Sorrento Therapeutics' Price Target to $26 F..
MT
01/29SORRENTO THERAPEUTICS : B. Riley Starts Sorrento Therapeutics at Buy With $26 Price Target
MT
01/21SORRENTO THERAPEUTICS : Alliance Global Partners Starts Sorrento Therapeutics at Buy With ..
MT
2020Arcturus expects its COVID-19 vaccine to be ready by Q1 2021
RE
More recommendations
Press releases
12/07Sorrento Begins Enrollment in Phase 2 Trial of Resiniferatoxin (RTX) for the Treatment ..
GL
12/07Sorrento Begins Enrollment in Phase 2 Trial of Resiniferatoxin (RTX) for the Treatment ..
GL
12/07Sorrento Therapeutics' Clinical Laboratory Receives Accreditation From the College of A..
AQ
12/07Scilex Holding Company, a Sorrento Therapeutics Inc. Subsidiary, and Vickers Vantage Co..
AQ
12/06Sorrento Receives Orders of COVISTIX for Commercial Launch in Brazil
GL
More press releases
Upcoming event on SORRENTO THERAPEUTICS, INC.